TG Therapeutics Inc common stock (TGTX:NASDAQ)

$29.27 0.24 (0.83%)

watchlist-icon
search-icon
Profile Icon

This Week's Average Sentiment Analysis Score (0 to 100): 90

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]

Change Analysis Timeline Daily Weekly Monthly subspinner

Analysed TG Therapeutics Inc common stock (TGTX:NASDAQ) News Sources

Precision BioSciences Receives $7.5M in Proceeds from TG Therapeutics for Azer-cel Clinical Milestone in Multiple Sclerosis

Yahoo Finance

13 Most Profitable Growth Stocks to Buy Right Now

Insider Monkey

TGTX stock
TGTX stock price
TGTX stock price today
TGTX stock prediction
TGTX earnings date
TGTX news
TGTX price
TGTX share
TGTX share price
TGTX shares
TGTX ceo
TGTX premarket
$TGTX
TGTX ticker
TGTX after hours
TGTX stock
TGTX stock price
TGTX stock price today
TGTX stock prediction
TGTX earnings date
TGTX news
TGTX price
TGTX share
TGTX share price
TGTX shares
TGTX ceo
TGTX premarket
$TGTX
TGTX ticker
TGTX after hours

TG Therapeutics Inc common stock (TGTX:NASDAQ) FAQs

toggle

What is the current price of TG Therapeutics Inc common stock (TGTX:NASDAQ)?

The current price of TG Therapeutics Inc common stock (TGTX:NASDAQ) is $29.27.


toggle

TG Therapeutics Inc common stock (TGTX:NASDAQ) absolute price change since previous trading day?

The absolute price change of TG Therapeutics Inc common stock (TGTX:NASDAQ) since the previous trading day is $0.24.


toggle

TG Therapeutics Inc common stock (TGTX:NASDAQ) percentage price change since previous trading day?

The percentage price change of TG Therapeutics Inc common stock (TGTX:NASDAQ) since the previous trading day is 0.83%.


toggle

What is This Week's average sentiment score for TG Therapeutics Inc common stock (TGTX:NASDAQ)?

This Week's average sentiment score for TG Therapeutics Inc common stock (TGTX:NASDAQ) is 90 out of 100.


toggle

What is This Week's average sentiment for TG Therapeutics Inc common stock (TGTX:NASDAQ)?

This Week's sentiment for TG Therapeutics Inc common stock (TGTX:NASDAQ) is .


Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.